Zydus Lifesciences has informed that it enclosed a copy of press release dated January 30, 2024 titled ‘Zydus Lifesciences launches Rexigo™, the oral once-a-day pill for advanced prostate cancer patients in India’.
The above information is a part of company’s filings submitted to BSE.